United States Contrast Agents Market Outlook to 2033 - Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others

The “United States Contrast Agents Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Contrast Agents market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles)

The United States Contrast Agents Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Contrast Agents Market.
Global corporate-level profiles of key companies operating within the United States Contrast Agents Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Contrast Agents is segmented as follows:

Computed Tomography (CT) Contrast Agents
Magnetic Resonance Imaging (MRI) Contrast Agents
Ultrasound Contrast Agents (Microbubbles)

Reasons to Buy

The United States Contrast Agents Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Contrast Agents Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Contrast Agents Market, United States

3.1 Contrast Agents Market, United States, Revenue ($m), 2018-2033
3.1.1 Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Contrast Agents Market, United States, Volume (Units), 2018-2033
3.2.1 Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Contrast Agents Market, United States, Average Price ($) , 2018-2033
3.4 Contrast Agents Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Contrast Agents Market

4.1 Bracco Imaging SpA
4.1.1 Company Overview
4.2 GE HealthCare Technologies Inc
4.2.1 Company Overview
4.3 Bayer AG
4.3.1 Company Overview
4.4 Lantheus Medical Imaging Inc
4.4.1 Company Overview
4.5 Guerbet SA
4.5.1 Company Overview

5 Contrast Agents Market Pipeline Products

6 Financial Deals Landscape

6.1 Equity Offerings
6.1.1 Monopar Therapeutics Raises USD19.2 Million in Public Offering of Common Stock

7 Recent Developments

7.1 Corporate Communications
7.1.1 May 12, 2025: Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
7.2 Financial Announcements
7.2.1 Nov 07, 2024: Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
7.2.2 Aug 08, 2024: Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024
7.3 Government and Public Interest
7.3.1 Aug 20, 2024: Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
7.4 Other Significant Developments
7.4.1 Feb 03, 2025: GE HealthCare to invest $138m in Irish contrast media facility
7.5 Product News
7.5.1 Jul 15, 2024: Vanderbilt Scientists Develop New Tool That Could Lead to Noninvasive “liquid biopsies”
7.6 Strategy And Business Planning
7.6.1 Jun 02, 2025: ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

8 Appendix

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

List of Tables

Table 1: Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Contrast Agents Market, United States, Volume (Units), 2018-2033
Table 5: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), 2018-2033
Table 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), 2018-2033
Table 7: Contrast Agents Market, United States, Average Price ($), 2018-2033
Table 8: Contrast Agents Market, United States, Company Share by Revenue ($m), 2024
Table 9: Contrast Agents Market Pipeline Products
Table 10: Monopar Therapeutics Raises USD19.2 Million in Public Offering of Common Stock
Table 11: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country

List of Figures

Figure 1: Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Contrast Agents Market, United States, Volume (Units), 2018-2033
Figure 5: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), 2018-2033
Figure 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), 2018-2033
Figure 7: Contrast Agents Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Bayer AG
Bracco Imaging SpA
GE HealthCare Technologies Inc
Guerbet SA
Lantheus Medical Imaging Inc

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4457EUR$4,995USD£3,930GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€8914EUR$9,990USD£7,860GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13371EUR$14,985USD£11,790GBP

The United States Contrast Agents Market report provides key information and data on:

Scope

United States Contrast Agents is segmented as follows:

Reasons to Buy

The United States Contrast Agents Market report helps you to develop:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

North America Contrast Agents Market Outlook to 2033 - Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others

United States Contrast Media Injectors Market Outlook to 2033 - Computed Tomography (CT) Injectors, Magnetic Resonance Imaging (MRI) Injectors and Angiographic Injectors

U.S. Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, Magnetic Resonance Imaging (MRI), CT/X-ray), By Product (Iodinated, Microbubble, Gadolinium-Based), By End Use, And Segment Forecasts, 2025 - 2030

Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2025-2030

Positron Emission Tomography Market - Global Forecast 2025-2032